[A case of myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-related glomerulonephritis associated with Cogan's syndrome]. 1996

M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
First Department of Internal Medicine, School of Medicine, Kyorin University, Tokyo, Japan.

We report here a case of Cogan's syndrome associated with systemic vasculitis as well as myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-related glomerulonephritis. A 71-year-old woman with the diagnosis of aortitis syndrome and pulmonary fibrosis for 7 years, complained of vertigo and hearing impairment. A diagnosis of serous otitis media was made. Although steroid therapy was effective, the symptoms relapsed several times. Seven months after the first manifestation of aural symptoms, she developed painful red eyes bilaterally and proteinuria. On admission, perinuclear ANCA without cytoplasmic ANCA was detected by indirect immunofluorescence assay and MOP-ANCA was detected by enzyme linked immunosorbent assay using the 363 ELISA Unit. Renal biopsy showed necrotizing crescentic glomerulonephritis without immune deposits. A diagnosis of atypical Cogan's syndrome with systemic vasculitis and pulmonary fibrosis was made from the clinical and histological findings. As nephrotic syndrome progressed after admission, she was started on high-dose corticosteroid administration. Urinary protein and other symptoms, except for hearing acuity, improved in parallel with a decrease in the MPO-ANCA titer to normal values. While tapering the dose of corticosteroid, the MPO-ANCA titer increased again and dyspnea occurred. Although pulse methylpredonisolone therapy was performed, the patient died of respiratory failure complicated with sepsis. Postmortem lung biopsy showed pulmonary fibrosis and massive alveolar hemorrhage. The findings of this case study suggest that MPO-ANCA may be closely related to the pathogenesis of Cogan's syndrome.

UI MeSH Term Description Entries
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D010034 Otitis Media with Effusion Inflammation of the middle ear with a clear pale yellow-colored transudate. Middle Ear Effusion,Otitis Media, Secretory,Otitis Media, Serous,Ear Effusion, Middle,Ear Effusions, Middle,Effusion, Middle Ear,Effusions, Middle Ear,Middle Ear Effusions,Secretory Otitis Media,Serous Otitis Media
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006319 Hearing Loss, Sensorineural Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM. Deafness Neurosensory,Deafness, Neurosensory,Deafness, Sensoryneural,Neurosensory Deafness,Sensorineural Hearing Loss,Sensoryneural Deafness,Cochlear Hearing Loss,Hearing Loss, Cochlear,Deafnesses, Neurosensory,Deafnesses, Sensoryneural,Neurosensory Deafnesses,Sensoryneural Deafness,Sensoryneural Deafnesses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D014657 Vasculitis Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. Angiitis,Angiitides,Vasculitides

Related Publications

M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
October 2003, Clinical nephrology,
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
January 2015, Nihon Jinzo Gakkai shi,
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
November 2020, Clinical immunology (Orlando, Fla.),
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
January 2016, Internal medicine (Tokyo, Japan),
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
October 2000, Ryumachi. [Rheumatism],
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
January 2005, Modern rheumatology,
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
October 2021, BMJ case reports,
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
March 2013, Cellular immunology,
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
June 1994, Nihon Jinzo Gakkai shi,
M Suzuki, and Y Arimura, and S Minoshima, and K Fukuoka, and N Miyake, and S Ishizuka, and A Soejima, and K Nakabayashi, and K Kitamoto, and T Nagasawa
November 2015, Kidney international,
Copied contents to your clipboard!